omega-n-methylarginine has been researched along with Hypertension, Portal in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (64.29) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 1 (7.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Moeller, M; Pohl, S; Ripoll, C; Thonig, A; Zipprich, A | 1 |
| Cao, H; Chen, XS; Wu, ZY | 1 |
| Ding, X; Gao, GW; Gao, RZ; Liu, CA; Wang, JJ; Yao, ZX | 1 |
| Cawley, T; Docherty, JR; Geraghty, J; Osborne, H | 1 |
| Breslin, E; Cawley, T; Docherty, JR; Geraghty, J; Osborne, H | 1 |
| Delchier, JC; Dhumeaux, D; Dutreuil, C; Lamarque, D | 1 |
| Docherty, JR; McCormick, PA; McDaid, J | 1 |
| Bories, PN; Gadano, AC; Heller, J; Lebrec, D; Moreau, R; Sogni, P | 1 |
| Edwards, BS; Kamath, PS; Miller, VM; Rorie, DK; Tyce, GM | 1 |
| Barletta, G; Del Bene, R; Gentilini, P; La Villa, G; Laffi, G; Masini, E; Pantaleo, P; Perfetto, F; Tarquini, R; Vecchiarino, S; Vizzutti, F | 1 |
| Cao, H; Chen, Z; Kuang, Y; Wu, Z; Zhou, J | 1 |
| Chen, Z; Jiao, Z; Kuang, Y; Wang, Q; Wu, Z; Yuan, J; Zeng, M; Zhou, H; Zhou, J | 1 |
| Fulton, D; Gratton, JP; Groszmann, RJ; Iwakiri, Y; McCabe, TJ; Sessa, WC; Tsai, MH | 1 |
| Bosch, J; Moncada, S; Piqué, JM; Pizcueta, MP; Whittle, BJ | 1 |
1 trial(s) available for omega-n-methylarginine and Hypertension, Portal
| Article | Year |
|---|---|
Hemodynamic, renal, and endocrine effects of acute inhibition of nitric oxide synthase in compensated cirrhosis.
Topics: Aged; Aldosterone; Blood Pressure; Cross-Over Studies; Enzyme Inhibitors; Female; Glomerular Filtration Rate; Hemodynamics; Humans; Hypertension, Portal; Kidney; Liver Cirrhosis; Male; Mesenteric Artery, Superior; Middle Aged; Nitric Oxide Synthase; Nitrites; Norepinephrine; omega-N-Methylarginine; Placebos; Renin; Sodium; Vascular Resistance | 2001 |
13 other study(ies) available for omega-n-methylarginine and Hypertension, Portal
| Article | Year |
|---|---|
Hepatic arterial vasodilation is independent of portal hypertension in early stages of cirrhosis.
Topics: Animals; Blotting, Western; Dose-Response Relationship, Drug; Hepatic Artery; Hypertension, Portal; Hypoxia-Inducible Factor 1, alpha Subunit; Immunohistochemistry; Liver Cirrhosis; Male; Methoxamine; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Perfusion; Rats, Wistar; Vascular Resistance; Vasodilation | 2015 |
[The effect of PGI2 on formation and development of hyperdynamic circulatory state in portal hypertensive rats].
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Cyclooxygenase Inhibitors; Disease Models, Animal; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hypertension, Portal; Male; Nitric Oxide; Nitric Oxide Synthase; Nitroarginine; omega-N-Methylarginine; Random Allocation; Rats; Rats, Sprague-Dawley | 2003 |
Effects of tumor necrosis factor, endothelin and nitric oxide on hyperdynamic circulation of rats with acute and chronic portal hypertension.
Topics: Acute Disease; Animals; Antineoplastic Agents; Chronic Disease; Endothelin-1; Enzyme Inhibitors; Hypertension, Portal; Liver; Liver Circulation; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Portal Vein; Rats; Rats, Wistar; Tumor Necrosis Factor-alpha | 2004 |
Effects of portal hypertension on responsiveness of rat mesenteric artery and aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Animals; Aorta; Arginine; Blood Pressure; Decerebrate State; Endothelium, Vascular; Hypertension, Portal; Male; Mesenteric Arteries; Microspheres; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Norepinephrine; omega-N-Methylarginine; Portal Vein; Potassium Chloride; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Investigations of the function of the vascular endothelium in portal hypertensive rats.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Acetylcholine; Analysis of Variance; Animals; Coloring Agents; Disease Models, Animal; Endothelium, Vascular; Hypertension, Portal; Male; Mesenteric Arteries; Methylene Blue; Microspheres; Muscle Contraction; Muscle Relaxation; Muscle, Smooth, Vascular; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Prostaglandin Endoperoxides, Synthetic; Rats; Rats, Wistar; Thromboxane A2; Vasoconstrictor Agents | 1995 |
Increased gastric bicarbonate secretion in portal hypertensive anesthetized rats: role of prostaglandins and nitric oxide.
Topics: Anesthesia; Animals; Bicarbonates; Blood Pressure; Capillary Permeability; Cyclooxygenase Inhibitors; Dinoprostone; Enzyme Inhibitors; Gastric Mucosa; Hemodynamics; Hypertension, Portal; Indomethacin; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Nitroprusside; omega-N-Methylarginine; Portal Pressure; Prostaglandins; Rats; Rats, Sprague-Dawley; Stomach | 1997 |
Cardiovascular actions of nitric oxide synthase inhibition in the portal hypertensive rat.
Topics: Animals; Blood Pressure; Cardiac Output; Enzyme Inhibitors; Hypertension, Portal; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Rats; Rats, Wistar | 1998 |
Vascular nitric oxide production during the development of two experimental models of portal hypertension.
Topics: Animals; Aorta, Thoracic; Disease Models, Animal; Guanidines; Hypertension, Portal; In Vitro Techniques; Liver Cirrhosis, Biliary; Male; Muscle Contraction; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Norepinephrine; omega-N-Methylarginine; Portal Vein; Rats; Rats, Sprague-Dawley; Sulfonamides; Thrombosis | 1999 |
Endothelin-1 modulates intrahepatic resistance in a rat model of noncirrhotic portal hypertension.
Topics: Animals; Arginine; Endothelin-1; Hypertension, Portal; In Vitro Techniques; Male; Nitric Oxide; omega-N-Methylarginine; Peptides, Cyclic; Perfusion; Rats; Rats, Inbred F344; Vascular Resistance; Vasoconstriction | 1999 |
Effects of nitric oxide inhibitor on prostacyclin biosynthesis in portal hypertensive rats.
Topics: 6-Ketoprostaglandin F1 alpha; Animals; Carbon Tetrachloride Poisoning; Enzyme Inhibitors; Epoprostenol; Hemodynamics; Hypertension, Portal; Male; Nitric Oxide Synthase; omega-N-Methylarginine; Portacaval Shunt, Surgical; Rats; Rats, Sprague-Dawley | 1999 |
[The role of nitric oxide in hyperdynamic circulation in portal hypertensive rats].
Topics: Animals; Arginine; Carbon Tetrachloride; Disease Models, Animal; Enzyme Inhibitors; Hemodynamics; Hypertension, Portal; Male; Nitric Oxide; Nitric Oxide Synthase; omega-N-Methylarginine; Portasystemic Shunt, Surgical; Rats; Rats, Sprague-Dawley | 1998 |
Phosphorylation of eNOS initiates excessive NO production in early phases of portal hypertension.
Topics: Adrenergic alpha-1 Receptor Agonists; Androstadienes; Animals; Enzyme Inhibitors; Hypertension, Portal; Ligation; Male; Mesenteric Artery, Superior; Methoxamine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; omega-N-Methylarginine; Phosphorylation; Portal Vein; Protein Serine-Threonine Kinases; Proto-Oncogene Proteins; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Vasoconstrictor Agents; Wortmannin | 2002 |
Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension.
Topics: Animals; Arginine; Blood Circulation; Constriction; Hypertension, Portal; Male; Nitric Oxide; omega-N-Methylarginine; Rats; Rats, Inbred Strains; Reference Values; Splanchnic Circulation | 1992 |